Sponsor or institution

Clinical trials and research at Minghui Pharmaceutical (Hangzhou) Ltd

• 12Clinical trials
• 2Countries

Newest trials

All recruiting trials (12)

• MH004 Ointment in non-segmental vitiligo: a phase 3 trial

  A 12-month randomized trial tests MH004 ointment to see if it helps facial vitiligo more than a placebo in people aged 12 to 75.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Beijing, Beijing Municipality · NCT07682506

• MHB018A injections for chronic moderate-to-severe thyroid eye disease

  This study tests whether MHB018A injections work better than a placebo for adults with chronic moderate-to-severe thyroid eye disease.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Coral Gables, Florida · NCT07622121

• Treating Active Thyroid Eye Disease with MHB018A vs placebo

  In people with active moderate-to-severe TED, this study tests whether an antibody called MHB018A can help reduce eye inflammation and swelling compared with a placebo.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Coral Gables, Florida · NCT07622108

• MHB009C for adults with advanced solid tumors

  This trial will try MHB009C, an experimental injectable drug, in adults with advanced solid tumors who have no standard treatment options.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07326488

• Extended MHB018A treatment for thyroid eye disease

  This extension tries continued MHB018A injections to reduce eye bulging (proptosis) in adults with moderate-to-severe thyroid eye disease who previously received placebo.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07262476

• MHB036C given with other cancer medicines for advanced lung cancer

  This study will try MHB036C together with other cancer medicines in adults with advanced lung cancer to see if the combination is safe and helps control tumors.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07229599

• MHB048C treatment for advanced solid tumors, including metastatic castration‑resistant prostate cancer

  This study will test whether the experimental drug MHB048C is safe and shows signs of benefit in adults with advanced solid tumors, including metastatic castration‑resistant prostate cancer.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07192120

• MHB042C for people with advanced solid tumors

  This study will try MHB042C injections in adults whose advanced solid tumors have stopped responding to standard treatments.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Guangzhou, Guangdong · NCT07192107

• MHB036C combined with MHB039A for advanced breast cancer and other advanced solid tumors

  This trial will test whether the injectable combination of MHB036C and MHB039A is safe, well tolerated, and can shrink or control tumors in adults with advanced breast cancer or other advanced solid tumors.

  Recruiting Phase 2 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07130383

• Combination of MHB088C and MHB039A for advanced solid tumors

  This will test whether combining two experimental drugs, MHB088C and MHB039A, is safe and can help adults with advanced solid tumors that haven't responded to standard treatments.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07126665

• MHB118C injection for advanced solid tumors

  This trial tests whether MHB118C injection is safe and shows signs of benefit in adults with advanced solid tumors who have exhausted standard treatment options.

  Recruiting Phase 1 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai · NCT07045454

• MHB046C injection for adults with advanced solid tumors

  This study will test whether MHB046C injections are safe and might shrink or control advanced solid tumors in adults who have no standard treatment options.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Guangzhou, Guangdong · NCT06985355

Quick answers

How many clinical trials run by Minghui Pharmaceutical (Hangzhou) Ltd are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (10 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 6, Phase 3: 4, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →